SCHEMBL6017536

SCHEMBL6017536

CC(C)NC(=O)C1CCN(CCCCCC(=O)N(C)CCOC(=O)N(c2ccccc2-c2ccccc2)N2CC[CH]CC2)CC1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 3/20 0.36
DRD2 P14416 3/20 0.36
HTR7 P34969 3/20 0.36
HTR6 P50406 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPK1 P28482 1/20 0.36
POLB P06746 1/20 0.36
CHRM3 P20309 6/20 0.35
SLC2A1 P11166 2/20 0.35
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6017485 0.91 CHRM3 (0.37) HTR1ADRD2HTR7HTR6MEN1
SCHEMBL6017445 0.83 CHRM2 (0.39) MEN1KMT2AALDH1A1MAPK1POLB
SCHEMBL6016864 0.81 BCHE (0.37) HTR1ADRD2HTR7HTR6ALDH1A1
SCHEMBL6017518 0.77 HTR1A (0.37) HTR1ADRD2HTR7HTR6MEN1
SCHEMBL2639275 0.76 CHRM2 (0.45) MEN1KMT2AALDH1A1CHRM3RAB9A
SCHEMBL6028157 0.76 ACHE (0.39) HTR1ADRD2HTR7HTR6ALDH1A1
SCHEMBL1362067 0.75 CHRM3 (0.62) CHRM3SLC2A1
SCHEMBL4691377 0.73 KMT2A (0.36) HTR1ADRD2HTR7HTR6KMT2A
SCHEMBL6021912 0.72 CHRM2 (0.56) ALDH1A1RAB9A
SCHEMBL4695275 0.71 CHRM2 (0.35) MEN1KMT2AALDH1A1CHRM3GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1723112-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2006-11-22 EP disclosed
WO-2005087736-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2005-09-22 WO disclosed